Alvandian Faezeh, Hosseini Elham, Hashemian Zohre, Khosravifar Mona, Movaghar Bahar, Shahhosein Maryam, Shiva Marzieh, Afsharian Parvaneh
Faculty of Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran.
Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Cell J. 2022 Jul 27;24(7):410-416. doi: 10.22074/cellj.2022.8051.
Transforming growth factor-beta (TGF-β) superfamily and its members that include bone morphogenetic protein 15 (BMP15), anti-Mullerian hormone (AMH), growth /differentiation factor-9 (GDF9), and their respective receptors: BMPR1A, BMPR1B, and BMPR2 have been implicated as key regulators in various aspects of ovarian function. The abnormal function of the ovaries is one of the main contributing factors to polycystic ovarian syndrome (PCOS), so this study aimed to investigate the mRNA expression profile of these factors in granulosa (GCs) and cumulus cells (CCs) of those patients.
The case-control research was conducted on 30 women (15 infertile PCOS and 15 normo-ovulatory patients, 22≤age ≤38 years old) who underwent ovarian stimulation for in vitro fertilization (IVF)/ intracytoplasmic sperm injection (ICSI) cycle. GCs/CCs were obtained during ovarian puncture. The expression analysis of the aforementioned genes was quantified using real-time polymerase chain reaction (PCR).
AMH and BMPR1A expression levels were significantly increased in GCs of PCOS compared to the control group. In contrast, GDF9, BMP15, BMPR1B, and BMPR2 expressions were decreased. PCOS' CC showed the same expression patterns. GDF9 and AMH were effectively expressed in normal CCs, and BMP15 and BMPR1B in normal GCs (P<0.05).
Differential gene expression levels of AMH and its regulatory factors and their primary receptors were detected in granulosa and cumulus cells in PCOS women. Since the same antagonist protocol for ovarian stimulation was used in both PCOS and control groups, the results were independent of the protocols. This diversity in gene expression pattern may contribute to downstream pathways alteration of these genes, which are involved in oocyte competence and maturation.
转化生长因子-β(TGF-β)超家族及其成员,包括骨形态发生蛋白15(BMP15)、抗苗勒管激素(AMH)、生长/分化因子9(GDF9),以及它们各自的受体:BMPR1A、BMPR1B和BMPR2,已被认为是卵巢功能各个方面的关键调节因子。卵巢功能异常是多囊卵巢综合征(PCOS)的主要促成因素之一,因此本研究旨在调查这些因子在PCOS患者颗粒细胞(GCs)和卵丘细胞(CCs)中的mRNA表达谱。
对30名接受卵巢刺激以进行体外受精(IVF)/卵胞浆内单精子注射(ICSI)周期的女性(15名不孕PCOS患者和15名排卵正常的患者,年龄22≤年龄≤38岁)进行病例对照研究。在卵巢穿刺期间获取GCs/CCs。使用实时聚合酶链反应(PCR)对上述基因的表达分析进行定量。
与对照组相比,PCOS患者GCs中AMH和BMPR1A的表达水平显著升高。相反,GDF9、BMP15、BMPR1B和BMPR2的表达降低。PCOS患者的CCs表现出相同的表达模式。GDF9和AMH在正常CCs中有效表达,BMP15和BMPR1B在正常GCs中有效表达(P<0.05)。
在PCOS女性的颗粒细胞和卵丘细胞中检测到AMH及其调节因子及其主要受体的基因表达水平存在差异。由于PCOS组和对照组使用了相同的卵巢刺激拮抗剂方案,结果与方案无关。这种基因表达模式的多样性可能导致这些基因的下游途径改变,而这些基因与卵母细胞的能力和成熟有关。